SCOLR Pharma announced that Daniel Wilds had resigned as CEO of the company and as a member of its board of directors.
Xceleron announced that Michael Butler, Ph.D., formerly president and CSO of Aptuit, has been named president and CEO.
Paul Laikind, Ph.D. has resigned as Metabasis Therapeutics' president and CEO to pursue other opportunities. Dr. Laikind will continue to serve as a member of the board of directors. In conjunction with Dr. Laikind's resignation, Mark Erion, Ph.D., chief scientific officer and executive vice president of research and development and a member of Metabasis' board of directors, has been named president, chief executive officer and chief scientific officer.
Andrew Kay has been appointed president and CEO of Algeta and will take up the role on 19 January 2009.
Par Pharmaceutical announced the resignation of Veronica Lubatkin, executive vice president and chief financial officer, effective March 6, 2009, to pursue other opportunities. Lawrence Kenyon will join Par on December 15th as executive vice president of finance and will assume the role of chief financial officer on March 9, 2009. Kenyon resigned from Alfacell where he was president, chief financial officer and corporate secretary.
Epitomics has named Zhiqiang An, Ph.D. as chief scientific officer.
OSI Pharmaceuticals has named former sanofi aventis executive Pierre Legault as chief financial officer, treasurer and executive vice president.
Bionovo has named Willa Hsueh, M.D., to the company's scientific advisory board.
Antigenics said that Peter Thornton has resigned from the company's board due to potential conflicts of interest regarding Irish drugmaker Elan.
William Shanahan has been appointed to its board of directors of Life Technologies.
Xoma has added John Varian to its board of directors.
Achaogen announced the appointments of Thomas B. King and Christopher T. Walsh, Ph.D., to its Board of Directors.
DelSite announced that George DeMott, chairman of the board of directors for the company, has resigned his position as chairman. DeMott will continue to serve on the board until his term ends in May 2009.